Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis

The main aim of this study is to compare the 2 medications denosumab and zoledronic acid for patients with beta-thalassemia major induced osteoporosis. Patients with B-thalassemia major induced osteoporosis will undergo baseline assessment of the bone densitometry by bone density (DEXA) scan as a st...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassin, Mohamed A., Abdel Rahman, Mohamed O., Hamad, Anas A., Poil, Abdul Razzakh, Abdelrazek, Mohamed T., Hussein, Radwa M., Kassem, Nancy A., Fadul, Afraa M., Elkourashy, Sarah A., Nashwan, Abdulqadir J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748343/
https://www.ncbi.nlm.nih.gov/pubmed/33371098
http://dx.doi.org/10.1097/MD.0000000000023637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748343/
https://www.ncbi.nlm.nih.gov/pubmed/33371098
http://dx.doi.org/10.1097/MD.0000000000023637

Ejemplares similares